Takeda Pharmaceutical (TAK)

• Market cap: $56.4B
• 1 day: 0.56%
• 5 days: -3.2%
• 1 month: -0.17%
• 3 months: 25.6%
• 6 months: 16.96%
• Year to date: 14.34%
• 1 year: 19.07%
• 5 years: -1.33%
• 10 years: 7.33%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Employees: 47,455